KLOX: Klox Technologies, Inc. - Summary | Jitta

Klox Technologies, Inc.

NASDAQ:KLOX

Notice
Stock data is unavailable or the company’s delisted.
Price
n/a
Loss Chance
58.4%
0.90JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (68)
Recent Business Performance (75)
Financial Strength (4)
Return to Shareholders (0)
Competitive Advantage (19)
Jitta Signs
Operating MarginDeclined
Recent Business PerformanceEarning decline 13.42% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
0.90
n/a
3.13
97.08%
COMPANY DESCRIPTION
Klox Technologies, Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of skin and soft tissue disorders. The company focuses on developing and commercializing its BioPhotonic technology platform for indications in the areas of dermatology, wound care, and oral health. It offers LumiCleanse, a product for the treatment for acne vulgaris; LumiBel for cosmetic skin care; and LumiHeal, a product for the treatment of chronic, acute, and surgical wounds along with burns, as well as for post-surgical scars. The company also offers PERIO-1, a non-invasive adjunct treatment for scaling and root planing. Its PERIO-1 is also used for the treatment of gingivitis. Klox Technologies, Inc. was incorporated in 2007 and is based in Laval, Canada with an additional office in Milan, Italy.